A recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have ...

EXCLUSIVE: Loose Women star Nadia Sawalha has shared her heartbreak as she continues campaigning for the life-extending drug to be made available in England, Wales and Northern Ireland.

Loose Women panellist Nadia Sawalha has been campaigning for the life-changing drug Enhertu to be made available in Wales, ...

Tributes have been paid to "inspirational" Darlington grandmother and campaigner Heather Sawyer who has sadly passed away after a ...

Erika P. Hamilton, MD, discusses the patient population with breast cancer enrolled in the TROPION-PanTumor01 trial in relation to the efficacy of datopotamab deruxtecan.

The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to clinicians to help guide therapy in cancer patients.

Oncolytics stock soars as the company seeks an accelerated approval pathway for its lead candidate, pelareorep, to treat a ...

Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer ...

FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research ...

While some forms of cancer are seeing death rates fall, the world is witnessing a global surge in cancers among patients under 50 . New cases are rising 79% overall, with the fastest rise in windpipe ...

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of breast ...

USA News Group News Commentary – Although death rates for some cancers are declining, the world is facing a sharp increase in ...